C19H23NO12S, triclinic, P1̄ (no. 2), a = 8.3926(9) Å, b = 9.0469(6) Å, c = 15.3442(15) Å, α = 78.195(7)°, β = 74.352(9)°, γ = 70.169(8)°, V = 1047.08(18) Å3, Z = 2, Rgt(F) = 0.0538, wRref(F2) = 0.1289, T = 293(2) K
C19H22MoN2O7S, triclinic, P1̄ (no. 2), a = 7.9719(2) Å, b = 10.3854(2) Å, c = 13.1042(3) Å, α = 81.4...
In the title compound, C17H19NO2S2, the 2H-chromene ring system is nearly planar, with a maximum dev...
C22H19NO7, monoclinic, P21/n (no. 14), a = 7.5742(4) Å, b = 20.0688(12) Å, c = 13.2932(8) Å, β = 102...
C21H21N3O4S, triclinic, P1̄ (no. 2), a = 9.4256(9) Å, b = 10.1906(9) Å, c = 11.6539(9) Å, α = 101.89...
C22H22O5N2S, monoclinic, P21/n (no. 14), a = 8.1080(2) Å, b = 14.4763(4) Å, c = 18.2819(5) Å, β = 95...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
C13H12O4, triclinic, P1̄ (no. 2), a = 6.141(5) Å, b = 8.108(6) Å, c = 12.234(9) Å, α = 79.257(12)°,...
C18H17N3O9, monoclinic, P21/c (no. 14), a = 15.3768(3) Å, b = 7.4510(2) Å, c = 15.6673(5) Å, β = 102...
C23H23NO6, monoclinic, P21/n (no. 14), a = 7.5845(4) Å, b = 14.7024(5) Å, c = 18.1433(6) Å, β = 98.7...
C22H25NO5S⋅H2O, triclinic, P1̄ (no. 2), a = 8.8121(4) Å, b = 10.6053(4) Å, c = 12.7365(5) Å, α = 80....
C17H25NO4S2, monoclinic, P121/c1 (No. 14), a = 11.349(4) Å, b = 10.934(3) Å, c = 29.48(2) Å, β = 96....
C25H27CoN2NaO9S, monoclinic, P21/c (no. 14), a = 12.8169(11) Å, b = 7.9965(7) Å, c = 25.597(2) Å, β ...
C60H50Co2N9O15, triclinic, P1̅ (no. 2), a = 13.6074(19) Å, b = 13.9185(17) Å, c = 15.837(2) Å, α = 8...
In the structure of the title compound, C30H40O6S, the cyclohexene and heterocyclic rings are linked...
C13H12N2O3S, monoclinic, P21/c (no. 14), a = 12.3541(8) Å, b = 14.3818(10) Å, c = 7.3757(5) Å, β = 9...
C19H22MoN2O7S, triclinic, P1̄ (no. 2), a = 7.9719(2) Å, b = 10.3854(2) Å, c = 13.1042(3) Å, α = 81.4...
In the title compound, C17H19NO2S2, the 2H-chromene ring system is nearly planar, with a maximum dev...
C22H19NO7, monoclinic, P21/n (no. 14), a = 7.5742(4) Å, b = 20.0688(12) Å, c = 13.2932(8) Å, β = 102...
C21H21N3O4S, triclinic, P1̄ (no. 2), a = 9.4256(9) Å, b = 10.1906(9) Å, c = 11.6539(9) Å, α = 101.89...
C22H22O5N2S, monoclinic, P21/n (no. 14), a = 8.1080(2) Å, b = 14.4763(4) Å, c = 18.2819(5) Å, β = 95...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
C13H12O4, triclinic, P1̄ (no. 2), a = 6.141(5) Å, b = 8.108(6) Å, c = 12.234(9) Å, α = 79.257(12)°,...
C18H17N3O9, monoclinic, P21/c (no. 14), a = 15.3768(3) Å, b = 7.4510(2) Å, c = 15.6673(5) Å, β = 102...
C23H23NO6, monoclinic, P21/n (no. 14), a = 7.5845(4) Å, b = 14.7024(5) Å, c = 18.1433(6) Å, β = 98.7...
C22H25NO5S⋅H2O, triclinic, P1̄ (no. 2), a = 8.8121(4) Å, b = 10.6053(4) Å, c = 12.7365(5) Å, α = 80....
C17H25NO4S2, monoclinic, P121/c1 (No. 14), a = 11.349(4) Å, b = 10.934(3) Å, c = 29.48(2) Å, β = 96....
C25H27CoN2NaO9S, monoclinic, P21/c (no. 14), a = 12.8169(11) Å, b = 7.9965(7) Å, c = 25.597(2) Å, β ...
C60H50Co2N9O15, triclinic, P1̅ (no. 2), a = 13.6074(19) Å, b = 13.9185(17) Å, c = 15.837(2) Å, α = 8...
In the structure of the title compound, C30H40O6S, the cyclohexene and heterocyclic rings are linked...
C13H12N2O3S, monoclinic, P21/c (no. 14), a = 12.3541(8) Å, b = 14.3818(10) Å, c = 7.3757(5) Å, β = 9...
C19H22MoN2O7S, triclinic, P1̄ (no. 2), a = 7.9719(2) Å, b = 10.3854(2) Å, c = 13.1042(3) Å, α = 81.4...
In the title compound, C17H19NO2S2, the 2H-chromene ring system is nearly planar, with a maximum dev...
C22H19NO7, monoclinic, P21/n (no. 14), a = 7.5742(4) Å, b = 20.0688(12) Å, c = 13.2932(8) Å, β = 102...